miR-17-92 cluster appears to be able, together with c-myc, to induce B-cell lymphoma development in a mouse model [8,9] and to increase proliferation of normal and malignant lung cells, while inhibiting their differentiation [41]. This evidence concerns the gene MYC and B-cell non-Hodgkin lymphoma.